"Stop any stimulant and caffeine-containing supplements, including energy drinks," he says
Future progress will depend on phenotype-matched designs with clear biological purposes, measurable evidence and feasible translational paths, with rational simplification likely to be more clinically useful than further functional stacking
Insurers, including Medicare, consider ICERs analyses in deciding whether to cover treatments
If brand-name is the right fit whether for clinical reasons, insurance coverage, or personal preference we can help coordinate fulfillment through authorized channels such as LillyDirect, when appropriate
The UK medicines regulator, the MHRA, has updated the product information for healthcare professionals and patients regarding the "small risk of severe acute pancreatitis in patients taking GLP-1s." While rare, the sheer scale of GLP-1 use in the UK with one recent study suggesting 1.6 million adults had used them in the last 12 months, and 3.3 million were interested in trying them in the following year makes it important for clinicians and patients to be aware of the warning signs of pancreatitis, said the regulator
Severe kidney or liver disease